Filters

Nifuroxazide manufacturers

Filters

nifuroxazide

Tablets 100 mg, 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Status OTC Available pack sizes: 100 mg - 24 tablets, 200 mg - 12 tablets. Indication Acute or chronic diarrhea in the course of bacterial infections of the gastrointestinal tract Classification Generic
Manufacturer #279
This company is a leading manufacturer of drugs, dietary supplements, cosmetics, and medical devices with nearly 40 years of experience. They produce high-quality products to meet the health needs of patients, delivering over 48 million packages annually. The company prides itself on its Polish heritage, being one of the few family-owned pharmaceutical companies with entirely local capital. They aim to be a leader in the pharmaceutical industry, focusing on quality, innovation, and customer satisfaction. The company values honesty, responsibility, high standards, flexibility, openness to solutions, and continuous development, employing over 1,500 people in Lower Silesia.

Manufacturer usually replies in 30 days

nifuroxazide

Tablets 100 mg, 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #20828

​Established in 1989, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 31 countries and regions. With a dedicated team of over 1,500 employees, it operates GMP-certified facilities in Poland, producing a diverse range of products including tablets, capsules, creams, balms, external liquids, and powder sachets. As a GMP manufacturer, it holds certifications such as cGMP and ISO 9001:2000, ensuring adherence to international quality standards. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

 

Manufacturer usually replies in 30 days

nifuroxazide

Oral solution 220 mg/5 ml - 100 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
RX Indication: Acute or chronic diarrhea in the course of bacterial infections of the gastrointestinal tract Classification Generic
Manufacturer #279
This company is a leading manufacturer of drugs, dietary supplements, cosmetics, and medical devices with nearly 40 years of experience. They produce high-quality products to meet the health needs of patients, delivering over 48 million packages annually. The company prides itself on its Polish heritage, being one of the few family-owned pharmaceutical companies with entirely local capital. They aim to be a leader in the pharmaceutical industry, focusing on quality, innovation, and customer satisfaction. The company values honesty, responsibility, high standards, flexibility, openness to solutions, and continuous development, employing over 1,500 people in Lower Silesia.

Manufacturer usually replies in 30 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.